Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Allarity Therapeutics, Inc. (ALLR) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.32M |
|
-- |
|
-- |
|
$4.13M |
|
$-4.13M |
|
$1.81M |
|
$-2.32M |
|
$-2.32M |
|
$-2.32M |
|
$-2.32M |
|
$-2.32M |
|
$-2.32M |
|
$-4.13M |
|
$-4.12M |
|
15.54M |
|
15.54M |
|
$-0.15 |
|
$-0.15 |
|
| Balance Sheet Financials | |
$20.88M |
|
$0.32M |
|
$0.32M |
|
$21.20M |
|
$9.04M |
|
-- |
|
-- |
|
$9.04M |
|
$12.17M |
|
$12.17M |
|
$12.17M |
|
14.62M |
|
| Cash Flow Statement Financials | |
$-8.17M |
|
$0.00M |
|
$8.58M |
|
$19.53M |
|
$17.80M |
|
$-1.73M |
|
$0.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.31 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
0.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-8.17M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-19.07% |
|
-19.07% |
|
-10.94% |
|
-19.07% |
|
$0.83 |
|
$-0.53 |
|
$-0.53 |
|